nejm tirzepatide New in the January 30, 2025, issue of NEJM: for Heart Failure and Obesity (SUMMIT trial) https://nej.md/4hRGaTY Continuation of Oral Anticoagulation during TAVI (POPular PAUSE TAVI trial) https://nej.md/3XllHys Lentiviral Gene Therapy What to Expect on Tirzepatide:

But its not just about preference

Staying hydrated, eating smaller meals, and choosing protein-rich foods help minimize discomfort

Several fibrosis scores were estimated such as AST/ALT ratio, fibrosis-4 (FIB-4) index, AST to platelet ratio index (APRI) and NAFLD fibrosis score (NFS)

Early studies also show that they help reduce inflammation and improve cardiovascular health

More studies are underway, and I will update this blog as I learn about new findings

PlexusDx monitors these changes through your ongoing check-ins, helping your provider adjust your tirzepatide dose and track whether your lipid goals are being met